Response to the Letter to the Editor ‘Reply to “Clinical Safety and Efficacy of Secondary Prophylactic Pegylated G-CSF in Advanced Pancreatic Cancer Patients Treated with mFOLFIRINOX: A Single-center Retrospective Study” by Dr. Peng Chen’

Detalles Bibliográficos
Autores principales: Yamao, Kentaro, Watanabe, Tomohiro, Kudo, Masatoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2019
Materias:
Letters to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7118373/
https://www.ncbi.nlm.nih.gov/pubmed/31735800
http://dx.doi.org/10.2169/internalmedicine.3958-19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7118373/
https://www.ncbi.nlm.nih.gov/pubmed/31735800
http://dx.doi.org/10.2169/internalmedicine.3958-19

Ejemplares similares